decreases glutaminergic transmission in the spinal cord. It inhibits central neuronal sensitization and hyperalgesia by acting on calcium channels located at postsynaptic and presynaptic junctions resulting in the inhibition of the calcium influx thereby decreasing excitatory amino acid neurotransmission.
By decreasing the central sensory input processing, gabapentin is considered to provide preemptive analgesia hence, decreasing the incidence of hyperalgesia and allodynia after surgery.
The present study was undertaken to evaluate the efficacy of a single preemptive dose of gabapentin (600 mg) on the duration of postoperative analgesia in patients undergoing surgeries in spinal anesthesia (SA), which was considered as a primary outcome. Total opioid consumption (mean ± standard deviation [SD] ) in the first 24 h and postoperative sedation scores due to the somnolence effect of gabapentin were measured in both groups as secondary outcomes.
metHods
A prospective randomized observational study was planned in sixty patients undergoing surgeries in SA, for example, laminectomies, hernia repairs, total abdominal hysterectomies, and total knee replacement. Approval from the institutional ethics committee obtained. The sample size was calculated keeping the mean (SD) duration of analgesia as a primary outcome. The sample size was calculated based on the study done by Bafna et al. [6] with an alpha error of 5% and keeping the power of study at 80%. Minimum sample size calculated was 29 in each group; however, we took thirty subjects for each group.
The patients aged between 18 and 60 years in the American Society of Anesthesiologists (ASA) physical I or II were included in the study. The exclusion criteria included (a) patients who were unwilling to participate, (b) patients who had a history of known hypersensitivity to any drugs which were being used in study, (c) patients with spinal deformities and chronic back ache, (d) patients who were receiving any analgesics 24 h before the surgery, (e) patients undergoing lower segment cesarean section, and (f) patients suffering from epilepsy, liver disease, renal disease, suffering from any chronic pain syndrome, or having any psychiatric illness.
Preanesthetic check-up was performed. The patients were explained the Numeric Rating Scale (NRS) of pain, which is a 10 cm horizontal line with the extreme right end marked as "10" denoting the worst imaginable pain and the extreme left end marked as "0" as no pain. Patients were asked to rate their pain on the scale of ten.
Each patient was randomly allocated using sealed envelope in either of two groups -Group A (gabapentin) and Group B (placebo) using random number tables. Thirty patients of Group A received 600 mg gabapentin orally 2 h before surgery while the thirty patients of Group B received a placebo 2 h before surgery. In the operation theater, all patients were preloaded with the 15 ml/kg of intravenous (IV) balanced salt solution. SA was given with 3 ml of 0.5% hyperbaric bupivacaine at L2-L3/L3-L4 space. Standard monitoring included heart rate, noninvasive blood pressure, electrocardiography, and oxygen saturation. Significant hypotension (defined as >20% fall in mean arterial blood pressure) was treated with injection ephedrine and IV crystalloids.
Postoperative monitoring and assessment of pain were done by an independent observer who was blinded to the group allocation. Postoperative pain was managed with injection tramadol 2 mg/kg IV slow infusion. The pain was assessed postoperatively using NRS score at 2, 4, 8, 12, and 24 h. The rescue analgesia was administered when the NRS of pain was above three and the total duration of analgesia was noted in both groups. Total dose (mean ± SD) of rescue analgesia consumed was calculated for the 24 h. Sedation scale was assessed using the Ramsay Sedation Scale at 2, 4, 8, and 24 h. Any side effects such as nausea, vomiting, and urinary retention was noted.
Continuous variables such as age and weight, duration of anesthesia, and the duration of analgesia were analyzed with unpaired t-test. Sex and ASA grading were represented in percentages. Postoperative NRS scores and sedation scores were analyzed using nonparametric analysis (Mann-Whitney U-test). Statistical Package for Social Sciences (Version 15.0 Inc., Chicago IL, USA) software was utilized for analysis. The difference was considered statistically significant when P < 0.05.
results
The study enrolled sixty ASA physical status Class I and II patients of either sex, between 18 and 60 years, scheduled for elective surgeries under SA and allocated randomly into two groups, Group A (n = 30) and Group B (n = 30) [ Figure 1 ]. Demographic variables such as age weight, sex, duration of surgery, and type of surgery were comparable in both groups [ Table 1 and Figure 2 ].
When the total duration of analgesia (mean ± SD) in minutes was compared, Group A patients required first rescue analgesia at (288.79 ± 38.81) min whereas, in Group B patient's (mean ± SD) duration of analgesia lasted till (218.67 ± 37.62) min with P = 0.0001 which is significant.
[ Table 2 ].
Sedation scores were significantly higher in Group A at 2 h and 4 h post-SA. Overall mean (SD) sedation scores of Group A when compared with Group B at 24 h were significant (P = 0.0001) [ Table 2 and Figure 3 ]. Intergroup mean (SD) pain scores when compared at 2, 4, 8, 12, 24 h were lower in Group A [ Figure 4 ]. Cumulative (mean ± SD) pain scores when added after 24 h in Group A (7.57 ± 2.31) were lower and significant in comparison to Group B (10.09 ± 2.61) with P = 0.0002 [ Table 2 ]. Total opioid consumption in milligrams postoperatively at 24 h was significantly lower in the Group A, (123.33 ± 34.07) when compared with Group B (140 ± 20.34) with P = 0.025. Postoperatively, six patients (two from Group A and four from Group B) had one episode of vomiting. All were treated with injection ondansetron 4 mg IV stat after which there were no further episodes. Urinary retention requiring one-time catheter evacuation of bladder was done in two patients each in both groups. No other significant side effects were recorded.
dIscussIon
Postoperative pain is heralded by the adverse outcomes such as prolonged hospital stay, impaired wound healing, and infections. Expansion of the knowledge of pain pathways leads to the inclusion of multimodal analgesia model as the recommended model combating postoperative pain with multiple drugs targeting not only the nociceptive inputs but also the inputs from viscera, inflammation, and neurogenic components.
This study demonstrates the analgesic efficacy of 600 mg of gabapentin in subjects undergoing surgeries under SA which appears to reduce abnormal hypersensitivity induced by inflammatory responses or nerve injury. [7] In our study, we selected the dose of 600 mg gabapentin administered 2 h before surgery keeping in mind the bioavailability of the drug which is described as disproportional. Studies have shown that increasing the dose beyond 600 mg the absorption is nonlinear and the bioavailability decreases. [8, 9] However, Elazzazi H et al., in their quest to find optimum dose of gabapentin concluded that 1500 mg oral dose given preoperatively reduced pain severity up to 24 h. [10] Schmidt et al., from their review concluded that higher preoperative dose of gabapentin (1200 mg) is more effective than lower doses and further added that continuing gabapentin postoperatively is more effective as compared to the single dose. [11] The preemptive administration of gabapentin approximately 2 h before surgery appears optimal to attain maximal plasma concentrations at the time of surgical stimuli. [12] Various studies have shown the efficacy of gabapentin in reducing the pain scores and increasing the mean duration of the analgesia when used for varied surgeries performed under SA such as total abdominal hysterectomy, orthopedic surgeries, and surgeries on spine. [6, 10, [12] [13] [14] The subjects who received gabapentin preoperatively, 2 h before incision in our study had significantly lower pain scores at all point of time compared to placebo [ Figure 4 ]. The mean duration of analgesia was prolonged in Group A in contrast to placebo group with P = 0.0001 [ Table 2 ]. Preincision analgesia has proved to be more effective in control of postoperative pain by modulating the central nervous system conditioning from deleterious effects of noxious stimuli. Anil Verma et al., [15] also demonstrated that 300 mg of gabapentin taken 2 h before surgery resulted in substantial reduction in pain and requirement of the epidural boluses in patients undergoing total abdominal hysterectomy.
Opioid sparing effect was observed in our study. The mean (SD) total dose of opioid (tramadol) consumed was significantly lower in Group A in comparison to placebo group with P = 0.025 [ Table 2 ]. Similar studies have proved that gabapentin enhanced the analgesic effect of morphine [16] and Eckhardt et al., [17] demonstrated that a 600 mg single dose of gabapentin also increases the adverse effects when these drugs were used concomitantly. Pandey et al. [18] showed that gabapentin reduced the requirement of fentanyl for postoperative pain relief in patients undergoing lumbar discoidectomy. Gabapentin, therefore, has a definite role in alleviating acute nociceptive and inflammatory pain and improved pain scores both at rest and with movement when administered as a preemptive analgesia thereby modulating the central neuronal mechanism. [19, 20] The contrary results have been reported by the systematic review and meta-analysis done by Fabritius et al., where there were inconsistency and lack of solid evidence regarding the role of gabapentin in reducing the 24 h opioid consumption with increased incidence of adverse effects when combined with multimodal analgesia. [21] Few studies have also confirmed the prolongation of both the sensory and motor recovery post-SA after the consumption of gabapentinoids. [22, 23] Chang et al., [24] review showed that gabapentin is well tolerated. Adverse effects, however, most commonly reported are dizziness, sedation or drowsiness, nausea, vomiting, and shivering. Sedation scores were significantly higher in Group A (P = 0.0001), and the difference was significant at 2 and 4 h [ Figure 3 ]. Studies have shown increased incidence of drowsiness varying from 33% to 42%. [6, 14] Sedation occurs primarily due to the inhibitory effect and modulation of the release of the excitatory neurotransmitter (glutamate, substance P, etc.) centrally. Meta-analysis by Peng et al., confirmed the increased incidence of the sedation and dizziness with gabapentin. [25] Decreased incidence of vomiting was noted in our study in gabapentin group (6.6%) with contrast to placebo group (13.3%). A study by Vasigh et al., [14] showed 10.3% patients had vomiting in gabapentin group as compared to placebo group with 39.5%. The theory behind its antiemetic effect is supposed to be due inhibition of neurotransmitter tachykinin. [26] Limitations of the study were due to the inclusion of heterogeneous group of surgeries which were not matched in both groups. Therefore, the extent of tissue handling and incision could have been a confounding factor in assessing the pain scores. Although an attempt was made to limit the variation between both groups, still some unforeseen bias might have been introduced. The study has shown that single dose of gabapentin (600 mg) given orally 2 h before surgery provides better pain control as compared to placebo. It reduces the total analgesic requirement during the postoperative period and delays the onset of pain after the surgery. Gabapentin is an effective tool in the armamentarium of anesthesiologist in the treatment of perioperative pain which can be used as a part of multimodal therapy.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
references

